124
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Identification of Three lncRNA-Related Prognostic Signatures in Gastric Cancer by Integrated Multi-Omics Analysis

, , , , , , , , , , , & ORCID Icon show all
Pages 1293-1308 | Received 05 Oct 2023, Accepted 06 Dec 2023, Published online: 21 Dec 2023

References

  • Sung H , FerlayJ , SiegelRLet al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin.71(3), 209–249 (2021).
  • He Y , WangY , LuanFet al. Chinese and global burdens of gastric cancer from 1990 to 2019. Cancer Med.10(10), 3461–3473 (2021).
  • Yusefi AR , BagheriLankarani K , BastaniP , RadinmaneshM , KavosiZ. Risk factors for gastric cancer: a systematic review. Asian Pac. J. Cancer Prev.19(3), 591–603 (2018).
  • Smyth EC , NilssonM , GrabschHI , Van GriekenNC , LordickF. Gastric cancer. Lancet396(10251), 635–648 (2020).
  • Fang C , WangW , DengJYet al. Proposal and validation of a modified staging system to improve the prognosis predictive performance of the 8th AJCC/UICC pTNM staging system for gastric adenocarcinoma: a multicenter study with external validation. Cancer Commun. (Lond)38(1), 67 (2018).
  • Tang S , LinL , ChengJet al. The prognostic value of preoperative fibrinogen-to-prealbumin ratio and a novel FFC score in patients with resectable gastric cancer. BMC Cancer20(1), 382 (2020).
  • Steele CD , AbbasiA , IslamSMAet al. Signatures of copy number alterations in human cancer. Nature606(7916), 984–991 (2022).
  • Baldacchino S , GrechG. Somatic copy number aberrations in metastatic patients: the promise of liquid biopsies. Semin. Cancer Biol.60, 302–310 (2020).
  • Deng X , LiS , KongFet al. Long noncoding RNA PiHL regulates p53 protein stability through GRWD1/RPL11/MDM2 axis in colorectal cancer. Theranostics10(1), 265–280 (2020).
  • Deng X , KongF , LiSet al. A KLF4/PiHL/EZH2/HMGA2 regulatory axis and its function in promoting oxaliplatin-resistance of colorectal cancer. Cell Death Dis.12(5), 485 (2021).
  • Bond GL , HuW , LevineA. A single nucleotide polymorphism in the MDM2 gene: from a molecular and cellular explanation to clinical effect. Cancer Res.65(13), 5481–5484 (2005).
  • Wang Z , DaiJ , HuNet al. Identification of new susceptibility loci for gastric non-cardia adenocarcinoma: pooled results from two Chinese genome-wide association studies. Gut66(4), 581–587 (2017).
  • Hussain S , TulsyanS , DarSAet al. Role of epigenetics in carcinogenesis: recent advancements in anticancer therapy. Semin. Cancer Biol.83, 441–451 (2022).
  • Shahabi S , KumaranV , CastilloJet al. LINC00261 Is an epigenetically regulated tumor suppressor essential for activation of the DNA damage response. Cancer Res.79(12), 3050–3062 (2019).
  • Lian Q , WangB , FanL , SunJ , WangG , ZhangJ. DNA methylation data-based molecular subtype classification and prediction in patients with gastric cancer. Cancer Cell Int.20, 349 (2020).
  • Alabi N , ShekaD , SiddiquiA , WangE. Methylation-based signatures for gastroesophageal tumor classification. Cancers (Basel)12(5), 1208 (2020).
  • Xu Y , WuT , LiFet al. Identification and comprehensive characterization of lncRNAs with copy number variations and their driving transcriptional perturbed subpathways reveal functional significance for cancer. Brief. Bioinform.21(6), 2153–2166 (2020).
  • Tan H , ZhangS , ZhangJet al. Long non-coding RNAs in gastric cancer: new emerging biological functions and therapeutic implications. Theranostics10(19), 8880–8902 (2020).
  • Huang Z , ZhouJK , PengY , HeW , HuangC. The role of long noncoding RNAs in hepatocellular carcinoma. Mol. Cancer19(1), 77 (2020).
  • Dragomir MP , KopetzS , AjaniJA , CalinGA. Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility. Gut69(4), 748–763 (2020).
  • Goodall GJ , WickramasingheVO. RNA in cancer. Nat. Rev. Cancer21(1), 22–36 (2021).
  • Cabili MN , TrapnellC , GoffLet al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev.25(18), 1915–1927 (2011).
  • Cui Y , CaoW , LiQet al. Evaluation of prostate cancer antigen 3 for detecting prostate cancer: a systematic review and meta-analysis. Sci. Rep.6, 25776 (2016).
  • Yuan Q , DengD , PanCet al. Integration of transcriptomics, proteomics, and metabolomics data to reveal HER2-associated metabolic heterogeneity in gastric cancer with response to immunotherapy and neoadjuvant chemotherapy. Front. Immunol.13, 951137 (2022).
  • Kong W , WangZ , WangB. Unveiling DNA damage repair-based molecular subtypes, tumor microenvironment and pharmacogenomic landscape in gastric cancer. Front Genet14, 1118889 (2023).
  • Lu X , MengJ , ZhouY , JiangL , YanF. MOVICS: an R package for multi-omics integration and visualization in cancer subtyping. Bioinformatics36(22–23), 5539–5541 (2020).
  • Mayakonda A , LinDC , AssenovY , PlassC , KoefflerHP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res.28(11), 1747–1756 (2018).
  • Mermel CH , SchumacherSE , HillB , MeyersonML , BeroukhimR , GetzG. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol.12(4), R41 (2011).
  • Love MI , HuberW , AndersS. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol.15(12), 550 (2014).
  • Shannon P , MarkielA , OzierOet al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res.13(11), 2498–2504 (2003).
  • Wu T , HuE , XuSet al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation (Camb.)2(3), 100141 (2021).
  • Gu Z , GuL , EilsR , SchlesnerM , BrorsB. circlize Implements and enhances circular visualization in R. Bioinformatics30(19), 2811–2812 (2014).
  • Morris TJ , ButcherLM , FeberAet al. ChAMP: 450k chip analysis methylation pipeline. Bioinformatics30(3), 428–430 (2014).
  • Tian Y , MorrisTJ , WebsterAPet al. ChAMP: updated methylation analysis pipeline for Illumina BeadChips. Bioinformatics33(24), 3982–3984 (2017).
  • Zhou RS , ZhangEX , SunQFet al. Integrated analysis of lncRNA–miRNA–mRNA ceRNA network in squamous cell carcinoma of tongue. BMC Cancer19(1), 779 (2019).
  • Liu TT , LiR , HuoCet al. Identification of CDK2-related immune forecast model and ceRNA in lung adenocarcinoma, a pan-cancer analysis. Front. Cell Dev. Biol.9, 682002 (2021).
  • Friedman J , HastieT , TibshiraniR. Regularization paths for generalized linear models via coordinate descent. J. Stat Softw.33(1), 1–22 (2010).
  • Huang ML , HungYH , LeeWM , LiRK , JiangBR. SVM-RFE based feature selection and Taguchi parameters optimization for multiclass SVM classifier. Sci. World J.2014, 795624 (2014).
  • Zhang M , QiC , WangZet al. Molecular characterization of ctDNA from Chinese patients with advanced gastric adenocarcinoma reveals actionable alterations for targeted and immune therapy. J. Mol. Med. (Berl.)99(9), 1311–1321 (2021).
  • Sukri A , HanafiahA , KosaiNR. The roles of immune cells in gastric cancer: anti-cancer or pro-cancer?Cancers (Basel)14(16), 3922 (2022).
  • Augustin JE , SoussanP , BassAJ. Targeting the complexity of ERBB2 biology in gastroesophageal carcinoma. Ann. Oncol.33(11), 1134–1148 (2022).
  • Wu J , ZhouZ , LiJet al. CHD4 promotes acquired chemoresistance and tumor progression by activating the MEK/ERK axis. Drug Resist. Update66, 100913 (2023).
  • Liang L , FangJY , XuJ. Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy. Oncogene35(12), 1475–1482 (2016).
  • Serra O , GalánM , GinestaMM , CalvoM , SalaN , SalazarR. Comparison and applicability of molecular classifications for gastric cancer. Cancer Treat. Rev.77, 29–34 (2019).
  • Duan Y , GongK , XuS , ZhangF , MengX , HanJ. Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics. Signal Transduct. Target. Ther.7(1), 265 (2022).
  • Moore LD , LeT , FanG. DNA methylation and its basic function. Neuropsychopharmacology38(1), 23–38 (2013).
  • Sun M , NieF , WangYet al. LncRNA HOXA11-AS promotes proliferation and invasion of gastric cancer by scaffolding the chromatin modification factors PRC2, LSD1, and DNMT1. Cancer Res.76(21), 6299–6310 (2016).
  • Su J , ChenD , RuanYet al. LncRNA MBNL1-AS1 represses gastric cancer progression via the TGF-β pathway by modulating miR-424-5p/Smad7 axis. Bioengineered13(3), 6978–6995 (2022).
  • Teng F , ZhangJX , ChenYet al. LncRNA NKX2-1-AS1 promotes tumor progression and angiogenesis via upregulation of SERPINE1 expression and activation of the VEGFR-2 signaling pathway in gastric cancer. Mol. Oncol.15(4), 1234–1255 (2021).
  • Ghafouri-Fard S , EsmaeiliM , TaheriM. H19 lncRNA: roles in tumorigenesis. Biomed. Pharmacother.123, 109774 (2020).
  • Liu F , CuiJ , XueD. LncRNA TRHDE-AS1 and MiR-1275 as promising prognostic biomarkers and effects on tumor cell progression in gastric cancer. Tohoku J. Exp. Med.261(1), 13–23 (2023).
  • Wu H , GuJ , ZhouDet al. LINC00160 mediated paclitaxel- and doxorubicin-resistance in breast cancer cells by regulating TFF3 via transcription factor C/EBPβ. J. Cell Mol. Med.24(15), 8589–8602 (2020).
  • Zhu W , ShengD , ShaoY , ZhangQ , PengY. STAT3-regulated LncRNA LINC00160 mediates cell proliferation and cell metabolism of prostate cancer cells by repressing RCAN1 expression. Mol. Cell Biochem.477(3), 865–875 (2022).
  • Zhang Z , YuW , TangDet al. Epigenomics-based identification of oestrogen-regulated long noncoding RNAs in ER+ breast cancer. RNA Biol.17(11), 1590–1602 (2020).
  • Anderson DM , AndersonKM , NelsonBRet al. A myocardin-adjacent lncRNA balances SRF-dependent gene transcription in the heart. Genes Dev.35(11–12), 835–840 (2021).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.